In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.67 million shares were traded. NMRA stock price reached its highest trading level at $1.81 during the session, while it also had its lowest trading level at $1.7301.
Ratios:
Our goal is to gain a better understanding of NMRA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.85 and its Current Ratio is at 6.85. In the meantime, Its Debt-to-Equity ratio is 0.15 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 27, 2025, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $14.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’25 when Aurora Daljit Singh sold 114,703 shares for $2.68 per share. The transaction valued at 307,026 led to the insider holds 0 shares of the business.
Aurora Family Trust bought 114,703 shares of NMRA for $307,027 on Nov 11 ’25. On Oct 27 ’25, another insider, Burow Kristina, who serves as the Director of the company, bought 1,915,700 shares for $2.61 each. As a result, the insider paid 4,999,977 and bolstered with 6,046,907 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NMRA now has a Market Capitalization of 302490432 and an Enterprise Value of 145979616.
Stock Price History:
The Beta on a monthly basis for NMRA is 3.21, which has changed by -0.8320755 over the last 52 weeks, in comparison to a change of 0.17823458 over the same period for the S&P500. Over the past 52 weeks, NMRA has reached a high of $11.57, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is -22.18%, while the 200-Day Moving Average is calculated to be 18.39%.
Shares Statistics:
The stock has traded on average 1.67M shares per day over the past 3-months and 915700 shares per day over the last 10 days, according to various share statistics. A total of 161.95M shares are outstanding, with a floating share count of 57.94M. Insiders hold about 65.32% of the company’s shares, while institutions hold 18.66% stake in the company. Shares short for NMRA as of 1765756800 were 6982708 with a Short Ratio of 4.18, compared to 1763078400 on 6095137. Therefore, it implies a Short% of Shares Outstanding of 6982708 and a Short% of Float of 10.459999999999999.
Earnings Estimates
. The current rating of Neumora Therapeutics Inc (NMRA) is the result of assessments by 7.0 analysts actively engaged in evaluating its market dynamics.The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.26 and low estimates of -$0.36.
Analysts are recommending an EPS of between -$1.39 and -$1.47 for the fiscal current year, implying an average EPS of -$1.43. EPS for the following year is -$1.03, with 7.0 analysts recommending between -$0.63 and -$1.45.
